6 min read
1 min read
Team Veristat Raised over $50K To Support Rare Cancer Research
Our Challenge: Join the Battle to Beat Rare Cancers
Our Impact: $150K Raised to Support Rare Cancer Research
For a fifth consecutive year, Team Veristat accepted this challenge in the 2019 Boston #cycleforsurvival event! We exceeded our goal of raising $50,000 to support rare cancer research.
At the 2019 Boston event on Saturday, Feb 2, 2019 our team:
- Exceeded our highest ever goal of raising over $50,000
- Was a Top Raising Team
- Doubled our team size since our first year
- Brought our total fundraising over the past 5 years to over $150,000
Every single one of our lives has been touched by cancer – ourselves, a family member, friend or a loved one.
It’s Not Too Late to Help Those Fighting Rare Cancers
Donate today. Your efforts will fight cancer and make a real impact for people who have few, if any, treatment options.
We help our clients navigate the challenges in clinical development and bringing medical innovations to market which motivates us to work hard and make a difference every day.
Help us make a continual and lasting impact by joining the battle against rare cancers!
Explore Related Services
- Download our Oncology Experience Fact Sheet
- Download our Oncology Infographic
- Learn more about our Rare Disease expertise
Get the Latest News
Categories
- Regulatory Consulting (118)
- Regulatory Submissions (113)
- Clinical Trial Regulations (96)
- COVID-19 (46)
- Strategic Consulting (28)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Success Stories (13)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Oncology (9)
- Clinical Operations/Monitoring (8)
- Medical Writing (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
2 min read
ASCO Annual Meeting
Apr 23, 2025 Veristat Events
Meet Veristat at the 2025 ASCO Annual Meeting
Advancing Oncology Therapies for Patients in Need
Veristat is proud to...